NCT01043068
Completed
Phase 4
A Pilot Study: The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients
Overview
- Phase
- Phase 4
- Intervention
- Cancer pain management
- Conditions
- Cancers, Pain
- Sponsor
- National Cancer Center, Korea
- Enrollment
- 25
- Locations
- 1
- Primary Endpoint
- Reduction in pain scores
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
The purpose of this study was to prospectively evaluate the effect of cancer pain management protocol on hospitalized cancer patients.
Investigators
Sang Myung Woo
MD
National Cancer Center, Korea
Eligibility Criteria
Inclusion Criteria
- •Hospitalized patient with the somatic and/or visceral pain having an untreated intensity greater than 3 on a 10 cm visual analog scale (VAS; 0 = no pain, 10 = unbearable pain)over the week prior to enrollment
- •A minimum age of 18 years
Exclusion Criteria
- •Opioid intolerance
- •No longer treatment for their underlying disease.
- •Intracerebral primary or metastatic lesion
- •Impaired sensory or cognitive function
- •Pregnant or lactating woman
- •Women of child bearing potential not using a contraceptive method
- •Sexually active fertile men not using effective birth control during medication of study drug and up to 6 months after completion of study drug if their partners are women of child-bearing potential
- •Any patients judged by the investigator to be unfit to participate in the study
Arms & Interventions
Pain control
Interventions based on published pain guideline. The interventions consisted of the following: (1) nursing pain assessment of current pain, worst pain, pain relief, and acceptability of pain; (2) feedback to guide analgesic prescribing by physician.
Intervention: Cancer pain management
Outcomes
Primary Outcomes
Reduction in pain scores
Time Frame: Jan 2010 - October 2010
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain PatientsCancerPainNCT03155516Taiwan Mundipharma Pharmaceuticals Ltd.150
Completed
Not Applicable
Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT StudyChronic LeukemiaHematopoietic and Lymphoid System NeoplasmLymphomaMalignant Solid NeoplasmMultiple MyelomaNCT06063603Mayo Clinic51
Unknown
Not Applicable
Development of an Intervention to Enhance Cancer Pain ManagementOther CancerNCT03752268Massachusetts General Hospital150
Terminated
Not Applicable
Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in FinlandBack PainNCT01787565Pfizer86
Unknown
Phase 2
Real-time Cancer Pain Assessment and InterventionMalignancyPainNCT01914107Sun Yat-sen University200